Rheumatoid arthritis

Epigenetic Regulatory Axis MIR22‐TET3‐MTRNR2L2 Represses Fibroblast‐Like Synoviocyte–Mediated Inflammation in Rheumatoid Arthritis

Arthritis RheumatolPublished Mechanistic study

Authors' conclusion

The key role of the MIR22-TET3-MTRNR2L2 pathway in RA-FLSs provided an experimental basis for further studies into the pathogenesis and related targets of RA from the perspective of FLSs.

Study context

Population
Synovium of patients with rheumatoid arthritis (RA) and arthritic mice; RA-FLSs
Methodological detailsMir22-/- and Tet3+/- mice collagen antibody-induced arthritis (CAIA) model, CIA model, in vitro RA-FLS experiments
  • Mir22-/- and Tet3+/- mice CAIA model
  • CIA model
  • In vitro RA-FLS experiments

Main finding

As reported in the abstract

  • MIR22 inhibited inflammation (Mir22-/- CAIA model and RA-FLS in vitro experiments)
  • MIR22 directly inhibits translation of TET3 in RA-FLSs by binding its 3' untranslated region
  • Tet3+/- CAIA mice showed less severe arthritis in vivo; in vitro experiments confirmed proinflammatory effect of TET3 in RA
  • Therapeutic effects of Mir22 angomir and Tet3 small interfering RNA (siRNA) validated in CIA model
  • TET3 exerts its proinflammatory effect by promoting 5hmC production in the promoter of its target MTRNR2L2 in RA-FLSs

Original publication

Epigenetic Regulatory Axis MIR22‐TET3‐MTRNR2L2 Represses Fibroblast‐Like Synoviocyte–Mediated Inflammation in Rheumatoid Arthritis. Arthritis Rheumatol. Published 7 March 2024. doi:10.1002/art.42795

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.